colchicine has been researched along with chronic COVID syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alunno, A; Carubbi, F; Cicogna, S; Del Pinto, R; Di Gregorio, N; Ferri, C; Grassi, D; Leone, S; Mancini, B; Viscido, A | 1 |
Finsterer, J | 1 |
2 other study(ies) available for colchicine and chronic COVID syndrome
Article | Year |
---|---|
Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; COVID-19; COVID-19 Drug Treatment; Female; Glucocorticoids; Humans; Male; Middle Aged; Pericardial Effusion; Pericarditis; Pericardium; Post-Acute COVID-19 Syndrome; SARS-CoV-2 | 2021 |
Letter to the Editor: There Is No Indication for Treating Long COVID Vaccination Syndrome With Colchicine.
Topics: Adult; Colchicine; COVID-19; Humans; Post-Acute COVID-19 Syndrome; RNA, Messenger; Vaccination | 2022 |